Patient Support Program Websites
Allergic Asthma and CIU Treatment | XOLAIR® (Omalizumab)
XOLAIR (omalizumab) for subcutaneous use is a prescription treatment for moderate to severe persistent allergic asthma not controlled with ICS and chronic idiopathic urticaria (CIU) in appropriate patients. See full safety & Boxed Warning
1,137,398
$
1,200.00
Allergic Asthma and CIU Treatment | XOLAIR® (Omalizumab)
Learn about moderate to severe persistent allergic asthma, Chronic Idiopathic Urticaria (CIU) and XOLAIR (omalizumab) treatment.
Not Applicable
$
8.95
Allergic Asthma and CIU Treatment | XOLAIR® (Omalizumab)
XOLAIR® (omalizumab) is a treatment for moderate to severe persistent allergic asthma and Chronic Idiopathic Urticaria (CIU) in appropriate patients.
Not Applicable
$
8.95
Domedica - Patient First - Leader nei programmi di supporto ai pazient
Domedica è leader nei programmi di assistenza paziente e nei servizi sanitari integrati in Italia.
Not Applicable
$
8.95
Domedica - Patient First - Leader nei programmi di supporto ai pazient
Domedica è leader nei programmi di assistenza paziente e nei servizi sanitari integrati in Italia.
Not Applicable
$
8.95
